Research programme: antifungals - Dorlin
Alternative Names: AJ-V-6D; Antifungals research programme - Dorlin; DP 214; Fatty acid synthase inhibitors research programme - Dorlin; Research programme: fatty acid synthase inhibitors - DorlinLatest Information Update: 28 Nov 2002
At a glance
- Originator Dorlin Pharmaceuticals; Nonindustrial source
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 28 Nov 2002 No development reported - Preclinical for Mycoses in USA (unspecified route)
- 12 Oct 2000 Preclinical development for Mycoses in USA (Unknown route)